Medicine and Dentistry
Adverse Event
100%
Loss of Appetite
100%
Epidermal Growth Factor Receptor
100%
Elderly Patient
100%
Non Small Cell Lung Cancer
100%
Retrospective Study
14%
Progression Free Survival
14%
Gene Mutation
14%
Survival Time
14%
Exanthem
14%
Alanine Aminotransferase
14%
Diarrhea
14%
Epidermal Growth Factor Receptor Kinase Inhibitor
14%
Aspartate Aminotransferase
14%
Oral Mucositis
14%
Pharmacology, Toxicology and Pharmaceutical Science
Adverse Event
100%
Loss of Appetite
100%
Epidermal Growth Factor Receptor
100%
Non Small Cell Lung Cancer
100%
Retrospective Study
25%
Progression Free Survival
25%
Survival Time
25%
Aspartate Aminotransferase
25%
Alanine Aminotransferase
25%
Epidermal Growth Factor Receptor Kinase Inhibitor
25%
Diarrhea
25%
Rash
25%
Oral Mucositis
25%
Keyphrases
Adverse Effects
100%
Appetite Loss
100%
Elderly Patients
100%
Non-small Cell Lung Cancer (NSCLC)
100%
Young Patients
28%
Epidermal Growth Factor Receptor-tyrosine Kinase Inhibitor (EGFR-TKI)
28%
Confidence Interval
14%
Statistical Significance
14%
Progression-free Survival
14%
Aspartate Aminotransferase
14%
Skin Rash
14%
Diarrhea
14%
Oral mucositis
14%
EGFR mutation
14%
Alanine Aminotransferase Elevation
14%